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Developing countries, where malaria is one of the most prevalent diseases, still rely on
traditional medicine as a source for the treatment of this disease. For the present study,
Trigonella foenum-graecum L. (fenugreek) were collected from Coimbatore, Tamilnadu, India.
The test plant has been used in India by traditional healers for the treatment of fever as well as
other diseases. The active principle was extracted out in different solvent systems to assess the
anti-plasmodial potential, with an aim that they can further be utilized to formulate drugs. In
vitro anti-plasmodial assay of the extracted fractions of fenugreek leaves was carried out using
laboratory adapted chloroquine sensitive and resistant Plasmodium falciparum isolates. Schizont
maturation inhibition assay was adopted to analyze the potential of the extracts. Ethanol
extract (50%) seemed to possess profound anti-plasmodial activity with IC50 value of 8.75 
0.35mgml
 1 and 10.25 0.35mgml
 1 against chloroquine sensitive and resistant P. falciparum
isolates, respectively. Among the investigated six fractions of the plant extracts, two were
found to have significant anti-plasmodial activity with IC50 values510mgml
 1, namely ethanol
and butanol extracts. Two extracts chloroform and ethyl acetate showed moderate activity
with IC50 values ranging from 10 to 20mgml
 1, and the other two extracts, hexane and water
appeared to be inactive with IC50 values 485mgml
 1. In addition, preliminary phytochemical
screening of the various extracts indicated the presence of alkaloids, saponin, tannin like
phenolic compounds, flavonoids and steroids.
Keywords: anti-plasmodial activity – malaria – medicinal plants – phytochemical screening –
Plasmodium falciparum
Introduction
Malaria is one of the most prevalent, devastating parasitic
infectious diseases in the world. Each year, 300–500 million
clinical cases and 1.5–2.7 million deaths associated
with malaria are reported globally (1). According to the
World Health Organization (WHO; 2), malaria is endemic
in 91 countries, predominantly in Africa, Asia and Latin
America, with about 40% of the world’s population at risk
(3). The problems of controlling malaria in these countries
are aggravated by inadequate health structures and
poor socioeconomic conditions. It is distributed widely,
mainly due to the multi-drug resistance developed by
Plasmodium falciparum. Of the four species of protozoan
parasite Plasmodium that cause malaria in humans,
P. falciparum is so far the most virulent and probably the
best studied pathogen after human immunodeficiency virus
and Mycobacterium tuberculosis (4). Despite over 22 years
of efforts, a human malaria vaccine has not yet gone into
routine use; nevertheless a considerable progress has been
made (5). The situation has become even more complex
over the last few years with prevalence of multi-drug
resistant strains and the cases of adverse reaction of
available anti-malarial drugs (6,7).
Mortality and morbidity due to malaria are a matter of
great concern throughout the world, especially in tropical
and subtropical regions. Even though casualty in children
below the age of 5 years is very high, the disease affects
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properly cited.all age groups. The pathogenesis occurs during erythro-
cytic stages. A peculiarity of P. falciparum is its ability to
adhere to vascular endothelium (cytoadherence) of eryth-
rocytes infected with maturing parasites. Now the severe
and complicated cerebral malaria due to P. falciparum is
compounded by the chloroquine-resistant parasites.
Chloroquine, though effective as a blood schizontocidal,
is ineffective or partially effective in resistant cases.
Spread of multi-drug-resistant strains of Plasmodium and
the adverse side effects of the existing anti-malarial drugs
have necessitated the search for novel, well tolerated and
more efficient anti-malarial drugs (6,8). Development of
new therapeutic approaches to malaria is very much
needed, since resistance of parasites to different anti-
malarials is fast developing. This initiated intensive
efforts for developing new anti-malarials from indigenous
plants (i.e. medicinal plants for tackling the ever-burning
problem and thus needless to say) has become one of the
prime focuses of research in malaria.
Herbal medicine remains one of the common forms of
therapy available for much of world’s population.
According to the WHO, about three-quarter of the
world’s population currently uses herbs and other forms
of traditional medicine to treat diseases (9). The
therapeutic properties of higher plants offer a virtually
untapped reservoir of potentially useful sources of drugs
that will continue to serve humankind into the 21st
century as they have done since dawn of history. Plants
medicinal potions have been exploited in treating
maladies from eczema and malaria to respiratory
disorders. The present study has been focused on
evaluating the potential of various extracts of Trigonella
foenum-graecum L. for anti-parasitic effects.
Materials and Methods
Plant Materials
The young leaves of T. foenum–graecum L. were harvested
in April 2004 from Coimbatore, Tamilnadu, India, based
on ethnomedical data and interview with local commu-
nities. This was authenticated by Botanical Survey of
India, Coimbatore division. The young leaves were
collected and washed thoroughly with water and air-
dried under shade and ground using a kitchen blender.
Plants Crude Extracts
The dried and ground plant materials (50g) were
extracted with 50% ethanol (600ml) for 48h using
soxhlet apparatus till the solvent became colorless in
the siphon. The ethanol extract was filtered
through Whatmann No. 1 (Whatmann International
Ltd, Maidstone, UK) paper and filtrates were freeze-
dried using lyophilizer to yield 36.86% w/w referred as
crude extracts. The residue was dried over night and then
extracted with 500ml water by shaking in a water bath
shaker at 70
 
C for 2h. Ten grams of crude extracts was
dissolved in 200ml of 50% ethanol and put in a
separating funnel. Hundred milliliter of hexane was
added to the above solution and shaken thoroughly for
5min and kept for 1h at room temperature. The upper
layer was collected as hexane fraction. To the remaining
lower fraction 100ml of chloroform was added and the
whole process was repeated. In this extraction process,
the upper layer was collected as chloroform fraction.
Another extraction was done with the addition of 100ml
ethyl acetate and upper layer was collected as ethyl
acetate fraction. To the left over fraction 100ml of
butanol was added to proceed in a similar manner and
upper layer was collected as butanol fraction. The
extracts were preserved at  20
 
C until use.
Phytochemical Screening of Plant Extracts
A preliminary phytochemical analysis of the plant
extracts was carried out using thin-layer chromatography
(TLC). Standard screening tests using conventional
protocol (10) were utilized for detecting the presence of
alkaloids, saponins, tannins/phenolic compounds, flavo-
noids and steroids.
Cultivation of P. falciparum and In Vitro
Anti-Plasmodial Tests
Laboratory adapted chloroquine sensitive and resistant
P. falciparum isolates were used for this study. The
parasites were maintained in continuous culture in
human red blood cells (O
+) diluted to 5% haematocrit
in RPMI 1640 medium supplemented with 25mM
HEPES, 30mM NaHCO3 and 10% human AB
+ serum
(11). The anti-plasmodial activity was performed in
triplicate in a 96-well microtiter plate, according to
WHO method that is based on assessing the inhibition
of schizont maturation (2). The culture was synchronized
using 5% aqueous solution of sorbitol (one portion of
pellet and nine portions of sorbitol) and kept for 5 to
7min at room temperature. This ensures killing of all
other stages except rings. It was centrifuged for 5min at
1500 r.p.m. The supernatant was discarded and the pellet
was washed with incomplete media twice. Parasitaemia
was adjusted to about 1% for the assay by diluting with
freshly washed RBCs. Extracts were dissolved in DMSO
(20mgml
 1) and diluted in medium to final concentra-
tion between 150 and 1mgml
 1. For the positive control
wells, parasitized red blood cells were devoid of plant
extracts and compounds whereas only non-parasitized
red blood cells were prepared for the negative control
wells. Fifty microliters from blood mixture media was
added to each well in plate and incubated in CO2
condition at 37.5
 
C for 24–36h. After incubation,
442 Anti-plasmodial activity of T. foenum–graecumcontents of the wells were harvested and stained for
30min in a 2% Giemsa solution pH 7.2. The developed
schizonts were counted against the total asexual parasite
count of 200. The percent inhibition at each concentra-
tion was determined and the mean of the least three IC50
values of parasite viability was calculated using mathe-
matical log-concentration–response probit analysis (12).
Results
Phytochemical Screening
The phytochemical screening of medicinal plant showed
the presence of alkaloids, saponin, tannin like phenolic
compounds, flavonoids and steroids. The presence of
alkaloids, tannin like phenolic compounds, steroids, in
ethanol extracts and alkaloids and tannin like phenolic
compounds in butanol extracts may contribute the anti-
plasmodial activity of this traditional herb (Table 1).
In vitro Anti-Plasmodial Studies
The results of in vitro anti-plasmodial activity of the
extracts are shown in Fig. 1. The most interesting anti-
plasmodial activity was obtained with 50% ethanol
extract against chloroquine sensitive and resistant
P. falciparum with the least IC50 value of
8.75 0.35mgml
 1 and 10.25 0.35mgml
 1, respectively.
Similarly, butanol fraction showed good IC50 value of
9.25 0.35mgml
 1 activity against sensitive P. falci-
parum; and moderate activity against resistant
P. falciparum IC50 value of 26.25 1.77mgml
 1. The
chloroform and ethyl acetate extract showed the IC50
against chloroquine sensitive P. falciparum was 16 0.00
and 16.50 0.07mgml
 1 where as IC50 value against
chlroroquine resistant P. falciparum isolate was
23.75 1.76mgml
 1. The other two extracts, hexane and
water appeared to be inactive with IC50 values
485mgml
 1.
Discussion
WHO experts say that the number of people worldwide
infected with malaria is still increasing at the rate of
about 5% annually despite the extensive programs
conducted by them (13). Preventing transmission by
mosquitoes, vaccination and drug treatment are the
three rapidly developing areas of malaria research.
Of the various means available for the control of malaria,
the use of effective drugs against the parasite remains
the most important and is likely to remain so for a
considerable time to come. A research for newer and
more efficient drugs has become an important aspect of
anti-malarial research (14). Plants have been used for
decades as traditional medicine for the treatment of
malaria. Malarial drugs such as quinine and artemisinin
have also been derived from plants and continue to be
effective in treating malaria. In the present study, an in
vitro assay of the anti-plasmodial activity of T. foenum–
graecum has been carried out.
The phytochemical screening of medicinal plants
showed presence of various components in the different
extracts, which may be responsible for the anti-
plasmodial activity. Alshawsh (3) reported that presence
of tannins, polysaccharides and proteins isolated from
Yemeni medicinal plants were responsible for the anti-
plasmodial activity. MacKinnon (15) demonstrated that
the presence of limnoids, and triterpenoids from
Azadirachta indica plant showed anti-malarial effect in
vitro. Some alkaloids (krukovin and limacrin) isolated
from Abuta grandifolia have been reported to be active
against P. falciparum (16). Previous phytochemical
investigations on Stephania abyssinica revealed the pre-
sence of hasubanan alkaloids (17–19) in the ethanol
extracts of the roots. In the present study, the alkaloid
fraction of ethanol and butanol extracts have been found
to exhibit the highest activity against P. falciparum. From
Piper species, isolation of pseudo-dipllapiol, benzoic-acid
derivatives, flavanones and chalcones has been reported
with anti-plasmodial effect (20,21). Muregi et al. (22)
have reported that the methanolic extracts of leaves and
root bark of Clerodendrum myricoides showed good
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Figure 1. In vitro anti-plasmodial effect of the crude extract/fraction
of T. foenum–graecum against chloroquine sensitive and resistant
P. falciparum isolates (Choroquine IC50 value=0.23mg/ml
–1 positive
control).
Table 1. Phytochemical screening of the various extracts of
T. foenum–graecum
Extracts Alkaloids Saponin Tannin/
Phenolic
compound
Flavonoids Steroids
Ethanol +–+ – +
Water –+ – – –
Hexane –– – – +
Chloroform –– – +–
Ethyl acetate –– – +–
Butanol +–+ – –
‘+’ Present; ‘–’ absent
eCAM 2010;7(4) 443activity against all the test isolates. C. myricoides has
been also reported to be useful in the management of
other parasitic diseases such as theileriosis.
In most reviews of plants used as anti-malarial,
ethanobotanical listings have been made with experiments
conducted against P. falciparum in individual studies (23).
The anti-plasmodial activity of S. abyssinica and Ajuga
remota was previously reported by Muregi et al. (22).
They found that the aqueous extract of plant leaves
showed the IC50 values420mgml
 1 which is in agreement
with our results. Previous bioassay-guided phytochemical
investigations showed anti-plasmodial (24) activity.
Siems et al. (25) have reported that the highest anti-
parasitic activity in vitro was detected in extracts of
Siparuna andina with an IC50 of 3.0mgml
 1 and
3.9mgml
 1 for P. falciparum strain poW and Dd2,
respectively, and also they have reported that prolonging
the incubation time of the anti-plasmodial assay to 72h
slightly increased the selectivity indices.
Ekebergia capensis hexane extract was found to exhibit
no anti-plasmodial activity in vitro against P. falciparum.
However, the chloroform, ethyl acetate, methanol and
water extracts gave good IC50 values (55mgml
 1)
suggesting that the plant extracts have a high in vitro
anti-plasmodial activity. The methanolic extract of
C. myricoides leaves showed good anti-plasmodial activity
(19). Similar findings were observed in the present study,
with high anti-plasmodial activity in ethanol, butanol,
chloroform and ethyl acetate extract.
The n-butanol extract of Eurycoma longifolia roots
displayed higher anti-plasmodial activity of 0.34mgml
 1
than its diethyl ether extract of 1.50mgml
 1. Both these
extracts were more potent than chloroquine diphosphate
(2.50mgml
 1) against the Gombak A isolate of
P. falciparum (12). Alshawsh (3) demonstrated that the
anti-plasmodial activity of aqueous extracts of Acalypha
fruticosa (IC50=1.6mgml
 1), Azardirachata indica
(IC50=2.0mgml
 1) and of Dendrosicyos socotrana
(IC50=2.3mgml
 1).
The specific changes in morphology produced by
particular extract hints at different modes of action of
the putative active principles in the extracts. The
parasitaemia also decreased with increasing concentration
of the extract reflected an inhibitory activity on parasite
replication. This may be indicative of a significant
potential for isolating purer compound. There are cases
where the individual isolated components may not exhibit
activity unlike their combinations in the crude extracts. It
is therefore necessary to carry out detailed phytochemical
studies to identify the active constituent of the test plant.
Crude extracts are the simplest of available medications
and are still promoted by WHO policies as emerging
alternative systems of medicine to reach the large
population not covered by formal medical care in
remote areas. Crude plant extract that showed lower
activity upon fractionation have yielded purer com-
pounds with potent anti-malarial activity.
In conclusion, some of the alkaloids and tannins like
phenolic compounds from T. foenum–graecum L. showed
potential anti-plasmodial properties against in vitro
culture of chloroquine sensitive and resistant P. falci-
parum. Further studies on these extracts are important
since they can probably serve as biochemical tools for the
understanding of the chloroquine resistance and the
mechanism of reversal in P. falciparum.
In this regard the result of this preliminary study is very
much encouraging. This is the first report on in vitro anti-
plasmodial effect of T. foenum–graecum. Further studies
can be carried out for the isolation of active principle and
elucidation of chemical structure with an objective of
exploring the possibility of using the component as oral/
parenteral drug for treating malarial infection.
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